Risk factors for previable premature rupture of membranes or advanced cervical dilation: A case control study

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 4, 2006, Pages 1168-1174

  Kilpatrick, Sarah J ^a   Patil, Rajita ^b   Connell, Jeness ^c   Nichols, Jessica ^a   Studee, Laura ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Advanced cervical dilation; Preterm premature rupture of membranes

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CASE CONTROL STUDY; CHLAMYDIASIS; CONTROLLED STUDY; DELIVERY; FEMALE; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; PARITY; PREGNANCY; PREGNANCY TERMINATION; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; RACE; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SMOKING CESSATION; URBAN POPULATION; UTERINE CERVIX DILATATION; VAGINITIS;

CASE-CONTROL STUDIES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; LABOR STAGE, FIRST; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33646044398     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.12.017     Document Type: Article

References (22)

1. French J.I., and McGregor J.A. The pathobiology of premature rupture of membranes. Semin Perinatol 20 (1996) 344-368
2. Mercer B.M., Goldenberg R.L., Meis P.J., Moawad A.H., Shellhaas C., Das A., et al. The preterm prediction study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. Am J Obstet Gynecol 183 (2000) 738-745
3. Dinsmoor MJ, Bachman R, Haney EI, Goldstein M, MacKendrick W. Outcomes after expectant management of extremely preterm premature rupture of the membranes 2003;190:183-7.
4. Hadi H.A., Hodson C.A., and Strickland D. Premature rupture of the membranes between 20 and 25 weeks' gestation: role of amniotic fluid volume in perinatal outcome. Am J Obstet Gynecol 170 (1994) 1139-1144
5. Killbride H.W., Yeast J., and Thibeault D.W. Defining limits of survival: lethal pulmonary hypoplasia after midtrimester premature rupture of membranes. Am J Obstet Gynecol 175 (1996) 675-681
6. Kurkinen-Raty M., Koivisto M., and Jouppila P. Perinatal and neonatal outcome and late pulmonary sequelae in infants born after preterm premature rupture of membranes. Obstet Gynecol 92 (1998) 408-415
7. Morales W.J., and Talley T. Premature rupture of membranes at <25 weeks: a management dilemma. Am J Obstet Gynecol 168 (1993) 503-507
8. Moretti M., and Sibai B.M. Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester. Am J Obstet Gynecol 159 (1988) 390-396
9. Rotschild A., Ling E., Puterman M.L., and Farquharson D. Neonatal outcome after prolonged preterm rupture of the membranes. Am J Obstet Gynecol 162 (1990) 46-52
10. Winn H.N., Chen M., Amon E., Leet T.L., Shumway J.B., and Mostello D. Neonatal pulmonary hypoplasia and perinatal mortality in patients with mid trimester rupture of amniotic membranes-A critical analysis. Am J Obstet Gynecol 182 (2000) 1638-1644
11. Locatelli A., Vergani P., Di Pirro G., Doria V., Biffi A., and Ghidini A. Role of amnioinfusion in the management of premature rupture of the membranes at <26 weeks' gestation. Am J Obstet Gynecol 183 (2000) 878-882
12. American College of Obstetricians and Gynecologists. Premature rupture of membranes: 2001 compendium of selected publications. Practice Bulletin #1, June 1998.
13. Lamont R.F. Recent evidence associated with the condition of preterm prelabour rupture of the membranes. Curr Opin Obstet Gynecol 15 (2003) 91-99
14. Ekwo E.E., Gosselink C.A., Woolson R., and Moawad A. Risks for premature rupture of amniotic membranes. Int J Epidemiol 22 (1993) 495-503
15. Hadley C.B., Main D.M., and Gabbe S.G. Risk factors for preterm premature rupture of the fetal membranes. Am J Peritnatol 7 (1990) 374-379
16. Harger J.H., Hsing A.W., Tuoamala R.E., Gibbs R.S., Mead P.B., Eschenbach D.A., et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 163 (1990) 130-137
17. Harger J.H. Cerclage and cervical insufficiency: an evidence-based analysis. Obstet Gynecol 100 (2002) 1313-1327
18. Riggs M.A., and Klebanoff M.A. Treatment of vaginal infections to prevent preterm birth: a meta-analysis. Clin Obstet Gynecol 47 (2004) 796-807
19. Macones G.A., Parry S., Elkousy M., Clothier B., Ural S.H., and Strauss J.F. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol 190 (2004) 1504-1508
20. Romero R., Chaiworapongsa T., Kuivaniemi H., and Tromp G. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 190 (2004) 1509-1519
21. Biggio J.R., Ramsey P.S., Cliver S.P., Lyon M.D., Goldenberg R.L., and Wenstrom K.D. Mid trimester amniotic fluid matrix metalloproteinase-8 (MMP-8) levels above the 90th percentile are a marker for subsequent preterm premature rupture of membranes. Am J Obstet Gynecol 192 (2005) 109-113
22. Simhan H.N., Caritis S.N., Krohn M.A., and Hillier S.L. The vaginal inflammatory milieu and the risk of early premature preterm rupture of membranes. Am J Obstet Gynecol 192 (2005) 213-218